Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bowe, US

Cameron Bowe, Morrisville, NC US

Patent application numberDescriptionPublished
20130268561SYSTEMS AND METHODS FOR COMPRESSING AND EXTRACTING INFORMATION FROM MARKETPLACE TAXONOMIES - A non-transitory processor-readable medium stores code that, when executed by a processor, causes the processor to receive a first file that is in a first file format and includes taxonomy data of a first marketplace; define a second file that is in a template file format and includes the taxonomy data of the first marketplace; and send the second file to a taxonomy platform such that inventory data is mapped to a taxonomy of the first marketplace. The code further causes the processor to receive a third file that is in a second file format and includes taxonomy data of a second marketplace; define a fourth file that is in the template file format and includes the taxonomy data of the second marketplace; and send the fourth file to the taxonomy platform such that the inventory data is mapped to a taxonomy of the second marketplace.10-10-2013

Caryn L. Bowe, Doylestown, PA US

Patent application numberDescriptionPublished
20140294762GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS - The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.10-02-2014
20150343080GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS - The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.12-03-2015

Caryn Lang Bowe, Doylestown, PA US

Patent application numberDescriptionPublished
20120107867GLYCOPEGYLATED ERYTHROPOIETIN - The present invention provides conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.05-03-2012

Craig Bowe, San Diego, CA US

Patent application numberDescriptionPublished
20140271853NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS - The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease including nocturnal acid breakthrough, or the symptoms associated therewith09-18-2014

Craig Bowe, Encintas, CA US

Patent application numberDescriptionPublished
20090092658NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS - The present invention relates to combinations of a proton pump inhibiting agent and at least one buffering agent that have been found to possess improved bioavailability, chemical stability, physical stability, dissolution profiles, disintegration times, as well as other improved pharmacokinetic, pharmacodynamic, chemical and/or physical properties. The present invention is directed to methods, kits, combinations, and compositions for treating, preventing or reducing the risk of developing a gastrointestinal disorder or disease including nocturnal acid breakthrough, or the symptoms associated therewith04-09-2009

Craig Michael Bowe, Encinitas, CA US

Patent application numberDescriptionPublished
20130216556ANTIBODY FORMULATIONS - Formulations of anti-VLA-1 antibodies are described.08-22-2013
20130287848Bromocriptine Formulations - The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.10-31-2013
20140010827ANTIBODY FORMULATIONS - Formulations of anti-VLA-1 antibodies are described.01-09-2014
20140187560BROMOCRIPTINE FORMULATIONS - The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycerine control in the treatment of type 2 diabetes.07-03-2014
20150056275CONTROLLED-RELEASE SOLID DOSAGE FORMS OF MESALAMINE - Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention relates to a method of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowel disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.02-26-2015

Patent applications by Craig Michael Bowe, Encinitas, CA US

Curtis M. Bowe, Chippewa Falls, WI US

Patent application numberDescriptionPublished
20140375020Removable Ball Hitch - A ball hitch has an actuator substantially disposed in a towing ball member. The actuator includes a pivotable handle, which in the stowed position forms part of the outer profile of the ball, but which can be pivoted upward to be used to rotate a shaft portion of the actuator. As the shaft rotates, it rotates a paddle with a cam surface housed in a support base for the ball hitch, which pushes on two interference balls. In the stowed position, the cam surface maintains the interference balls projecting outward from openings in the support base to secure the ball hitch into the towing vehicle. When the actuator turns the shaft, the cam surface allows the balls to retract into the support base without changing elevation of the shaft and cam surface.12-25-2014
20150028565Removable Chain Attachment Insert - A chain attachment insert has a body with a flat underside, and provides an open loop chain attachment for receiving a chain or hook in a socket in the bed of a truck. A T-bolt portion of the chain attachment insert is received in the socket. A hole through the body extends parallel to the axis of rotation defined by the T-bolt portion, and an interference peg is vertically slidable into the hole after rotation of the chain attachment insert relative to the socket. The interference peg then rests with a portion of the interference peg in the socket to interfere with and prevent the chain attachment insert from rotating relative to the socket. A lock secures the interference peg within the hole in the body.01-29-2015

Debra Heus Bowe, Kiel, WI US

Patent application numberDescriptionPublished
20150360896CONVEYING OR TRANSPORTING SUBSTRATES WITH LITTLE OR NO ADDED VACUUM - Provided are methods and apparatus for transporting either an entire web or discrete components of disposable products. The invention is a means of conveying the web or diaper components down the machine using mechanical forces to grip the nonwoven web and transfer it from one belt or roll to another without or reducing added vacuum. There is a carrier nonwoven web that goes down the length of the machine and other substrates are added on top of this. Methods and apparatus are disclosed to provide sufficient gripping to allow transport of diaper components through the fabrication process. Securing and releasing forces are supplied so that the components can be retained at some points and released at others.12-17-2015

Donald James Bowe, Zionsville, PA US

Patent application numberDescriptionPublished
20110318216Method and Atmosphere for Extending Belt Life in Sintering Furnace - Disclosed herein is a method and gas atmosphere for a metal component in a continuous furnace. In one embodiment, the method and gas atmosphere comprises the use of an effective amount, or about 1 to about 10 percent volume of endo-gas, into an atmosphere comprising nitrogen and hydrogen. In another embodiment, there is provided a method sintering metal components in a furnace at a one or more operating temperatures comprising: providing a furnace comprising a belt comprising a wire mesh material wherein the metal components are supported thereupon; and sintering the components in the furnace in an atmosphere comprising nitrogen, hydrogen, and effective amount of endothermic gas at the one or more operating temperatures ranging from about 1800° F. to about 2200° F. wherein the amount of endothermic gas in the atmosphere is such that it is oxidizing to the wire mesh material and reducing to the metal components.12-29-2011
20130270724Systems And Methods For Humidifying Gas Streams - Systems and methods are provided for humidifying a gas stream. Methods for providing a humidified gas stream comprise providing a dry gas, directing the dry gas to a humidification device, humidifying the dry gas to provide a humidified gas stream having an amount of moisture in excess of a predetermined amount, directing the humidified gas stream to a cooling device, cooling the humidified gas to a predetermined temperature, and directing the cooled humidified gas to a point of usage. Systems for providing a humidified gas stream comprise a dry gas stream, a humidification device configured to receive and humidify the dry gas stream to form a humidified gas stream having an amount of moisture in excess of a predetermined amount, and a cooling device configured to receive and cool the humidified gas stream to a predetermined temperature to form a cooled humidified gas stream.10-17-2013

Elizabeth Irene Bowe, San Diego, CA US

Patent application numberDescriptionPublished
20150183352PROTECTIVE COVER FOR CHILD CARRYING DEVICE - The present invention is directed to a protective cover for a child or other occupant in a carrying device. The protective cover is light, easy to use, and has adjustable straps, a storage compartment, handle access, lightweight fabric weights, and a window for providing access to the occupant, while simultaneously providing viewing ability to the outside environment for the occupant.07-02-2015
20150196126ATTACHABLE CHILD BLANKET AND NURSING COVER - The present invention is directed to an attachable blanket and a nursing cover for a child carrying device such as child car seat, stroller, infant swing, and the like. In particular, the nursing cover provides privacy for a nursing mother. The blanket is light, easy to use, and has adjustable straps for securely attaching the blanket to the carrying device.07-16-2015

Jason Bowe, West Lafayette, IN US

Patent application numberDescriptionPublished
20120130470STENT WITH PROTECTED BARBS - An endoluminal prosthesis is described and comprises a stent (05-24-2012

Jason S. Bowe, Blaine, MN US

Patent application numberDescriptionPublished
20130166012DELIVERY SYSTEM FOR STAGED STENT RELEASE - A prosthesis introducer system may include an introducer. A trigger wire release mechanism and a restraining member may be positioned near the distal end of the introducer. The system may include first and second trigger wires, each including a proximal portion releasably coupleable to a portion of a prosthesis and a distal portion coupled to the trigger wire release mechanism. The second trigger wire may be engaged by the restraining member. Each of the first and second trigger wires may include a taut portion. The second trigger wire may include a slack portion extending distally from the taut portion and positioned distal of the restraining member. Upon actuation of the trigger wire release mechanism, the first trigger wire may be releasable from the prosthesis and the second trigger wire may be releasable subsequent to the release of the first trigger wire.06-27-2013

Jason S. Bowe, West Lafayette, IN US

Patent application numberDescriptionPublished
20090030497Retention Wire For Self-Expanding Stent - A delivery system for self-expanding stents is provided. The delivery system includes a wire releasably attached to a portion of the self-expanding stent. The wire restrains movement of the stent when the stent is released from the delivery system. Thus, more accurate placement of the stent may be possible.01-29-2009
20120277845DELIVERY SYSTEM WITH RETRACTABLE PROXIMAL END - A medical device delivery system is described, the medical device delivery system comprising: a medical device carrier portion comprising a proximal end; a release mechanism cooperating with said medical device carrier portion and operable to release a medical device from said medical device carrier portion; and a proximal tip portion. The proximal tip portion comprises a largest outside diameter, a proximal end, a distal end, and a plurality of longitudinal lengths as measured from said proximal end to said distal end of said proximal tip portion, and is disposed proximal to said medical device carrier portion. The proximal tip portion further comprises and is operable between at least an extended longitudinal length and a retracted longitudinal length of said plurality of longitudinal lengths. Said extended longitudinal length is greater than said retracted longitudinal length.11-01-2012

Patent applications by Jason S. Bowe, West Lafayette, IN US

Mark A. Bowe, Derwood, MD US

Patent application numberDescriptionPublished
20080274966Biglycan and related therapeutics and methods of use - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.11-06-2008

Mark A. Bowe, Damascus, MD US

Patent application numberDescriptionPublished
20100130405BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.05-27-2010
20110053854TREATMENT OF MUSCULAR DYSTROPHIES AND RELATED DISORDERS - The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.03-03-2011
20110183910BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.07-28-2011
20120245095BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE - The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.09-27-2012
20150182589TREATMENT OF MUSCULAR DYSTROPHIES AND RELATED DISORDERS - The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.07-02-2015

Patent applications by Mark A. Bowe, Damascus, MD US

Michael D. Bowe, Doylestown, PA US

Patent application numberDescriptionPublished
20130022751DISPENSING DEVICE FOR BOTH FROTH AND NON-FROTH COATINGS - A dispensing device (01-24-2013
20130042961METHOD FOR SEALING FENESTRATION OPENINGS - Seal a fenestration opening that contains a gap having a width of greater than 1.6 millimeters by providing a dispersion having the following components dispersed in an aqueous phase: (i) a film-forming polymer binder having a glass transition temperature in a range of −100 degrees Celsius to −20 degrees Celsius; (ii) a shear thinning rheology modifier at a concentration sufficient to cause the dispersion to have a Brookfield viscosity greater than 300,000 centiPoise as measured using spindle #3 at 0.3 revolutions per minute; and (iii) optionally, a filler; and then spraying the dispersion directly onto the building elements within the fenestration opening so as to form a continuous coating over the building elements and gap within the fenestration opening; wherein there is an absence of reinforcement or sealing material filling or spanning the gap prior to spraying the dispersion over the gap.02-21-2013
20140044882METHOD FOR SEALING FENESTRATION OPENINGS - Seal a fenestration opening that contains a gap having a width of greater than 1.6 millimeters by providing a dispersion having the following components dispersed in an aqueous phase: (i) a film-forming polymer binder having a glass transition temperature in a range of −100 degrees Celsius to −20 degrees Celsius; (ii) a shear thinning rheology modifier at a concentration sufficient to cause the dispersion to have a Brookfield viscosity greater than 300,000 centiPoise as measured using spindle #3 at 0.3 revolutions per minute; and (iii) optionally, a filler; and then spraying the dispersion directly onto the building elements within the fenestration opening so as to form a continuous coating over the building elements and gap within the fenestration opening; wherein there is an absence of reinforcement or sealing material filling or spanning the gap prior to spraying the dispersion over the gap.02-13-2014
20150144249WEATHER-RESISTIVE BARRIERS FROM SELF COLLAPSING POLYURETHANE FOAMS - The present invention provides a self-collapsing, moisture curable one component polyurethane foam (1K PU) composition from moisture curable polyurethane prepolymers and to methods of making weather resistant barriers and formed in place gaskets therefrom. The foam compositions are packed under pressure with a blowing agent. In the methods, the foams are applied to gaps in the exterior (sheathing) of a building under construction and collapse on cure to enable application an aqueous weather barrier coating thereover within an hour. The foams also cure when applied on or adjacent a structure to form a foam gasket that enables installation of additional structural elements over or adjacent the foam gasket without bowing or damage to the structure treated.05-28-2015

Patent applications by Michael D. Bowe, Doylestown, PA US

Michael Damian Bowe, Doylestown, PA US

Patent application numberDescriptionPublished
20090107080Weather-resistive barrier for buildings - We form a weather-resistive barrier on a building by applying a compressible latex foam on the gaps between adjacent sheets of construction sheathing and coating04-30-2009
20090107611Weather-resistive barrier for buildings - We form a weather-resistive barrier on a building by applying a flexible and compressible latex foam comprising one or more polymer having a glass transition temperature of less than 25° C. on the gaps between adjacent sheets of construction sheathing and coating the sheets and the foam with an aqueous coating composition. The aqueous coating composition is flexible and can comprise the same one or more polymer as the polymer in the foam.04-30-2009
20090139181Weather-resistive barrier for buildings - We form a weather-resistive barrier on a building by applying a compressible latex foam on the joints between adjacent sheets of construction sheathing, with the sheets having been coated with an aqueous coating composition.06-04-2009
20110151225OPAQUE WET, SEE-THROUGH DRY WEATHER-RESISTIVE BARRIERS AND METHODS FOR MAKING - The present invention provides aqueous self-inspecting wet coatings or films that dry to form translucent to clear weather-resistive barriers on a substrate, preferably a building substrate such as sheathing. The coatings comprise, as a wet film, one or more aqueous emulsion or dispersion polymer that can form a film in use conditions and less than 6% pigment volume concentration (% PVC), of one or more opacifier, one or more extender in amounts up to critical % pigment volume concentration (CPVC), optionally, one or more pigment, and substantially no void, hollow core, or hollow sphere containing pigment. The coatings or films enable one to apply the correct amount of coating to make a weather barrier that dries to a see-through coating or film.06-23-2011
20110168332Light touch sealant applicator device - The present invention provides a device for applying a fluid sealant with a light touch, the device comprising a wand with a fluid sealant supply, either as part of the wand or as a separate supply tube, attached to the top of an applicator head via a universal joint, wherein the applicator head has a chamber on its underside which is sufficiently large to enable a constant supply of a fluid sealant to a substrate that is to be sealed, and the applicator head has an edge disposed around its lower periphery adapted to strike the sealant flat. In addition, the present invention provides methods of using the devices to form a seal, e.g. a weather-resistive barrier on a sheathed building structure, by applying a flexible and compressible foam to gaps in the structure. The foam may comprise one or more aqueous polymer having a glass transition temperature of less than 25° C.07-14-2011
20130149456OPAQUE WET, SEE-THROUGH WEATHER-RESISTIVE BARRIERS AND METHODS FOR MAKING - The present invention provides aqueous self-inspecting wet coatings or films that dry to form translucent to clear weather-resistive barriers on a substrate, preferably a building substrate such as sheathing. The coatings comprise, as a wet film, one or more aqueous emulsion or dispersion polymer that can form a film in use conditions and less than 6% pigment volume concentration (% PVC), of one or more opacifier, one or more extender in amounts up to critical % pigment volume concentration (CPVC), optionally, one or more pigment, and substantially no void, hollow core, or hollow sphere containing pigment. The coatings or films enable one to apply the correct amount of coating to make a weather barrier that dries to a see-through coating or film.06-13-2013

Patent applications by Michael Damian Bowe, Doylestown, PA US

Michael James Bowe, Seattle, WA US

Patent application numberDescriptionPublished
20110244932Dynamic Bracket - A method of conducting a tournament bracket game is provided which includes: a. allowing participants to change their selections as the tournament bracket game progresses based on tournament bracket game rules, the results of the tournament, and the results of participants' selections in the tournament and b. a scoring system that rewards correct selections by round with bonus points awarded for correctly selecting both teams that advance to a game. The tournament bracket game is designed specifically for application to the NCAA™ Men's College Basketball Tournament competition but is also applicable to any single elimination tournament bracket game whether sports based or not, including but not limited to soccer, rugby, tennis, hockey, baseball, football, volleyball, poker, bridge, backgammon, and chess.10-06-2011

Michael Joseph Bowe US

Patent application numberDescriptionPublished
20100186824Gas-to-Liquid Plant Using Parallel Units - A plant is provided for processing natural gas. The plant comprises two or more modules connected in parallel. The plant is configured to convert the associated gas into a material with a higher density. In addition, a method of processing gas associated with one or more oil wells. The method comprises the steps of: providing a modular plant comprising two or more modules in parallel wherein at least one of the modules is a robust module and at least one of the modules is an economical module; turning down one or more of the modules when productivity drops; switching off one or more of the modules at least when productivity drops beyond the turndown limit. The natural gas is treated in a Fischer-Tropsch unit.07-29-2010

Nathanial W. Bowe, Colchester, VT US

Patent application numberDescriptionPublished
20140239469INFORMATION ENCODING USING WIREBONDS - A method and structure for encoding information on an integrated circuit chip. The method includes selecting a set of chip pads of the integrated circuit chip for encoding the information; encoding the information during a wirebonding process, the wirebonding process comprising forming ball bonds on chip pads of the integrated circuit chip and wedge bonds on leadframe fingers adjacent to one or more edges of the integrated circuit chip, the ball bonds and the wedge bonds connected by respective and integral wires; and wherein the information is encoded by varying one or more wirebonding parameters on each chip pad of the set of chip pads, the wirebonding parameters selected from the group consisting of the location of a ball bond, the diameter of a ball bond, both the location and diameter of a ball bond, the location of a wedge bond and combinations thereof.08-28-2014

Steven Bowe, Apex, NC US

Patent application numberDescriptionPublished
20110287935HERBICIDAL COMPOSITIONS COMPRISING NAPTALAM - The present invention relates to herbicidal compositions comprising a) a herbicide compound A which is selected from Λ/-1-naphthylphthalamic acid (naptalam), the salts and esters thereof; and b) a herbicide compound B which is selected from b.1 3,6-dichloro-2-methoxybenzoic acid (dicamba), the salts and esters thereof; b.2 quinolinecarboxylic acid herbicides; b.3 pyridinecarboxylic acid herbicides; and b.4 aminocyclopyrachlor, the salts and esters thereof. The present invention also relates to the use of these compositions for controlling undesirable vegetation, in particular in crops, in turf or pasture, in rangeland, in fallow, or in forestry.11-24-2011
20120149577Aqueous Suspension Concentrate Formulations Containing Saflufenacil - The present invention relates to aqueous suspension concentrate formulation for plant protection comprising: 06-14-2012
20120157312Aqueous Concentrate Formulations Containing Saflufenacil and Glyphosate - The present invention relates to aqueous concentrate formulations for plant protection comprising: 06-21-2012
20120184434Low Volatile Amine Salts of Anionic Pesticides - The present invention relates to a salt comprising an anionic pesticide and a cationic polyamine of the formula (A) or (B) as described in the description. The invention further relates to an agrochemical composition comprising said salt. It also relates to a method for preparing said salt comprising combining the pesticide in its neutral form or as salt, and the polyamine in its neutral form or as salt. In addition, the invention relates to a method of combating harmful insects and/or phytopathogenic fungi. It also relates to a method of controlling undesired vegetation. Finally, the invention relates to seed comprising said salt.07-19-2012
20120231954LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE - The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethy)amino]sulfonyl]benzamide in the form of the anhydrate; N-(phosphonomethyl)glycine in the form of its free acid, in the form of the ammonium salt or a substituted ammonium salt or a mixture thereof; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and —C09-13-2012
20120302444LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL - The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide in the form of the crystalline anhydrate; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and C11-29-2012
20130102463Herbicidal Compositions - The present invention relates to herbicidal compositions comprising as herbicide A at least one protoporphyrinogen-IX oxidase inhibitor (PPO inhibitor), and at least one light detoxifying compound B, compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of said herbicidal composition to act on plants, their seed and/or their habitat.04-25-2013
20130225405Compositions Containing Identical Polyamine Salts of Mixed Anionic Pesticides - The present invention relates to a composition comprising a first salt, which contains a first anionic pesticide (A1) and a cationic polyamine (B), and a second salt, which contains a second anionic pesticide (A2) and a cationic polyamine (B), wherein both salts contain the same cationic polyamine (B), and wherein the cationic polyamine comprises at least two amino groups. It further relates to a method for preparing said comprising the step of contacting the first salt and the second salt. In addition, the invention relates to a method of combating harmful insects and/or phytopathogenic fungi, which comprises contacting plants, seed, soil or habitat of plants in or on which the harmful insects and/or phytopathogenic fungi are growing or may grow, plants, seed or soil to be protected from attack or infestation by said harmful insects and/or phytopathogenic fungi with an effective amount of said composition. It also relates to a method of controlling undesired vegetation, which comprises allowing a herbicidal effective amount of said composition to act on plants, their habitat or on seed of said plants. Finally, the invention relates to seed comprising said composition.08-29-2013
20140066309Method for Enhancing the Performance of a Pesticide with Guanidines - The present invention relates to a method for enhancing the performance of a pesticide comprising the step of contacting an adjuvant and the pesticide, wherein the pesticide is present in a concentration of less than 10 wt % in the resulting composition containing the adjuvant and the pesticide, and wherein the adjuvant contains a guanidine of formula (A) as defined below, and/or a salt thereof. The invention also relates to a composition comprising an auxin-herbicide and said adjuvant; to a use of said adjuvant for enhancing the performance of a pesticide; and to a method of controlling undesired vegetation, which comprises allowing a herbicidal effective amount of said composition to act on plants, their habitat or on seed of said plants.03-06-2014
20140080706METHOD OF PREPARING AN AQUEOUS TANK MIX COMPRISING A BASE - The present invention relates to a method of controlling undesired vegetation, and/or phytopathogenic fungi and/or undesired insect attack and/or regulating the growth of plants, which comprises the steps of A) preparing an aqueous tank mix which has a tank mix acidity of at least pH 5.0 comprising contacting a pesticide formulation, water, a base, and optionally an auxiliary; and B) allowing a pesticidal effective amount of said tank mix to act on crops, their habitat, on the undesired vegetation, on the respective pests, and/or on seed of said crops. It also relates to a use of a base for preparing an aqueous tank mix as defined in any of claims 03-20-2014
20140171319Aqueous Composition Comprising a Pesticide and a Base Selected from an Alkali Salt of Hydrogencarbonate - The invention relates to a liquid aqueous composition, which has a pH value of at least 7.0, comprising a pesticide and a base selected from an alkali salt of hydrogencarbonate; a method for preparing said composition comprising a step of contacting a pesticide and a base selected from an alkali salt of hydrogencarbonate; and a method of combating harmful insects and/or phytopathogenic fungi, which comprises contacting plants, seed, soil or habitat of plants in or on which the harmful insects and/or phytopathogenic fungi are growing or may grow, plants, seed or soil to be protected from attack or infestation by said harmful insects and/or phytopathogenic fungi with an effective amount of the composition.06-19-2014
20150031539Tank mix adjuvant comprising an alkyl polyglucoside and a base - The present invention relates to a method for preparing a tank mix, which comprises the step of contacting a pesticide formulation, water, and a tank mix adjuvant, wherein the tank mix adjuvant comprises an alkyl polyglucoside and a base selected from a carbonate and/or a phosphate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt % of the base. The invention also relates to a use of a tank mix adjuvant for increasing the efficacy of a pesticide, wherein the tank mix adjuvant comprises an alkyl polyglucoside and a base selected from a carbonate and/or a phosphate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt % of the base; to a tank mix adjuvant which comprises an auxiliary, an alkyl polyglucoside and a base selected from a carbonate and/or a phosphate, wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base; to a tank mix adjuvant which comprises an auxiliary, an alkyl polyglucoside and a base selected from a carbonate and/or a phosphate, wherein the tank mix adjuvant is present in form in form of a particulate solid, which contains at least 10 wt % of the base; and to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment.01-29-2015
20150051076Solid particulate tank mix adjuvant comprising a base selected from a carbonate and/or a phosphate - The present invention relates to q method for preparing a tank mix, which comprises the step of contacting a pesticide formulation, water, and a tank mix adjuvant, wherein the tank mix adjuvant comprises a base selected from a carbonate and/or a phosphate, and wherein the tank mix adjuvant is present in form of a particulate solid, which contains at least 10 wt % of the base. The invention also relates to a use of a tank mix adjuvant for increasing the efficacy of a pesticide, wherein the tank mix adjuvant comprises a base selected from a carbonate and/or a phosphate, and wherein the tank mix adjuvant is present in form of a particulate solid, which contains at least 10 wt % of the base; to a tank mix adjuvant which comprises an auxiliary and a base selected from a carbonate and/or a phosphate, wherein the tank mix adjuvant is present in form in form of a particulate solid, which contains at least 10 wt % of the base; and to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment.02-19-2015
20150051077Liquid or particulate tank mix adjuvant comprising a base selected from a mixture of carbonate and hydrogencarbonate - The present invention relates to q method for preparing a tank mix, which comprises the step of contacting a pesticide formulation, water, and a tank mix adjuvant, wherein the tank mix adjuvant comprises a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt % of the base. The invention also relates to a use of a tank mix adjuvant for increasing the efficacy of a pesticide, wherein the tank mix adjuvant comprises a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt % of the base; to a tank mix adjuvant which comprises an auxiliary and a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base; to a tank mix adjuvant which comprises an auxiliary and a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, wherein the tank mix adjuvant is present in form in form of a particulate solid, which contains at least 10 wt % of the base; and to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment.02-19-2015
20150051078Glyphosate tank mix adjuvant comprising a base selected from a carbonate and/or a phosphate - The present invention relates to a method for preparing a tank mix, which comprises the step of contacting a glyphosate formulation, water, and a tank mix adjuvant, wherein the tank mix adjuvant comprises a base selected from a carbonate or an alkali salt of a phosphate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt % of the base, wherein the tank mix has a tank mix acidity of at least pH 8.0, and wherein the tankmix contains at least 50 wt % water. The invention also relates to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment.02-19-2015
20150150249Drift control agent comprising polypropylene glycol and a triblock polymer - The present invention relates to a method for preparing a tank mix, which comprises the step of contacting a pesticide formulation, water, and a tank mix adjuvant which comprises a polypropylene glycol and a triblock polymer comprising at least one polyethyleneoxide moiety and at least one polypropyleneoxide moiety; to the tank mix adjuvant; to a pesticide formulation comprising the tank mix adjuvant: to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment, and to a use of the tank mix adjuvant or reducing the wind drift of a pesticide formulation.06-04-2015
20150173354Aqueous Composition Comprising Dicamba and a Drift Control Agent - The present invention relates to an aqueous composition comprising dicamba and a drift control agent; to a method for preparing a tank mix, which comprises the step of contacting water and said composition, and optionally further pesticides; to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or unde-sired insect or mite attack and/or for regulating the growth of plants, wherein the composition is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment; and finally to a use of the alkoxylate of the formula (I) as defined below for reducing the wind drift of an aqueous composition comprising a pesticide.06-25-2015
20150181865Adjuvant comprising a 2-propylheptylamine alkoxylate, sugar-based surfactant, and drift-control agent and/or humectant - The present invention relates to an adjuvant comprising a sugar-based surfactant; a drift control agent and/or a humectant; and an alkoxylate, wherein the alkoxylate is an amine alkoxylate (A) or a quaternized derivative (AQ) of the amine alkoxylate (A) as defined below. It further relates to a method of preparing said adjuvant by contacting07-02-2015
20150210723Low Volatile Amine Salts of Anionic Pesticides - The present invention relates to a salt comprising an anionic pesticide and a cationic polyamine of the formula (A) or (B) as described in the description. The invention further relates to an agrochemical composition comprising said salt. It also relates to a method for preparing said salt comprising combining the pesticide in its neutral form or as salt, and the polyamine in its neutral form or as salt. In addition, the invention relates to a method of combating harmful insects and/or phytopathogenic fungi. It also relates to a method of controlling undesired vegetation. Finally, the invention relates to seed comprising said salt.07-30-2015

Patent applications by Steven Bowe, Apex, NC US

Wade Bowe, Colorado Springs, CO US

Patent application numberDescriptionPublished
20100121346Compliant Guiding Catheter Sheath System - A guiding catheter system employs a compliant shaft with an inflatable balloon affixed to a distal portion of the shaft. The inflatable balloon includes channels that allow some amount of blood to flow past the balloon when inflated in a blood vessel. One or more inflation lumens is in fluid contact with the balloon and allows inflating the balloon from a proximal end of the catheter. A series of perfusion orifices may be included on the shaft proximal to the balloon.05-13-2010
20110098720SNARING SYSTEMS AND METHODS - Snaring systems and methods involve engaging objects such as pacemaker pacing leads within a patient. Physicians can use snaring systems having loops, tags, and roller mechanisms to remove a pacing leads from a patient. For example, snaring systems can be inserted through a jugular access site, engaged with a pacemaker pacing lead, and withdrawn through the jugular access site so as to remove a portion of the pacing lead. Lead extraction techniques can be employed to further dislodge the pacing lead from the patient.04-28-2011
20130338500CARDIOVASCULAR IMAGING SYSTEM - Embodiments of the present invention include a laser catheter that includes a catheter body, a light guide, and a distal tip that extends beyond the exit aperture of the light guide. In some embodiments, an imaging device is disposed on the distal tip such that the imaging device is distal relative to the exit aperture of the light guide. In some embodiments, the imaging device can be gated to record images during and/or slightly beyond periods when the laser catheter is not activated.12-19-2013
20140114298RAPID EXCHANGE BIAS LASER CATHETER DESIGN - Embodiments of a balloon biasing laser catheter are provided. In some embodiments, the laser catheter may include a distal tip that extends from the distal end of the catheter from a point near the light guide aperture. The distal tip may be disposed at the periphery of the catheter. In some embodiments, a balloon may be disposed between the light guide aperture and the distal tip, such that the a light guide extending from the aperture may be disposed proximate with the distal tip having the balloon in between. A retaining wire may be coupled with the distal tip and slidably coupled with the light guide. The retaining wire may keep the light guide biased relatively parallel with the distal tip and/or the catheter body when the balloon is inflated. The light guide may include a guidewire lumen the extends to the distal end of the distal tip.04-24-2014
20150342682SYSTEM AND METHOD OF ABLATIVE CUTTING AND VACUUM ASPIRATION THROUGH PRIMARY ORIFICE AND AUXILIARY SIDE PORT - A system for ablation and removal of occlusions from blood vessels is provided. Laser cutting systems and mechanical cutting systems are provided in catheter devices, the cutting systems operable to ablate, cut, dislodge, and otherwise remove occlusions within a blood vessel that may limit or prevent proper circulation. Aspiration systems are further provided, the aspiration systems operable to remove ablated, cut, or dislodged material through a primary orifice at the distal end of the catheter and/or through an auxiliary orifice, which may be on the side of the catheter.12-03-2015

Patent applications by Wade Bowe, Colorado Springs, CO US

Wade A. Bowe, Colorado Springs, CO US

Patent application numberDescriptionPublished
20090198221APPARATUS AND METHODS FOR DIRECTIONAL DELIVERY OF LASER ENERGY - In some embodiments, without limitation, the invention comprises a catheter having an elongated housing with a channel disposed therein. A laser delivery member is movable and at least partially disposed within the channel. A ramp is disposed within the housing at an angle to its central axis and proximate to its distal end. The ramp is adapted to move the distal end of the laser delivery member outwardly from the central axis of the housing. A guidewire biases the distal end of the laser delivery member generally inwardly toward the central axis of the housing. In some embodiments, without limitation, the offset of the central axis of the tip of the laser delivery member from the central axis of the housing is determined by adjusting the extent to which the laser delivery member travels on the ramp, and disposition of the laser delivery member on the guidewire maintains the offset tip substantially parallel to the central axis of the housing. Thus, in accordance with the invention, the distal end of the laser delivery member may be biased in a desired direction or offset, permitting ablation of an area larger than the area of the distal end of the catheter.08-06-2009
20100191315INNER AND OUTER TELESCOPING CATHETER DELIVERY SYSTEM AND METHOD - A method of delivering a payload to a destination vessel branching from a coronary sinus of a patient's heart. The method comprises inserting a catheter assembly into a right atrium of the patient's heart. The catheter assembly comprises an outer catheter and an inner catheter movably disposed within the open lumen of the outer catheter. The inner and outer catheters are operable to be rotated and translated relative to one another such that the distal end of the outer catheter can assume a selectable plurality of shapes appropriate for accessing the coronary sinus. The method further comprises locating and cannulating the patient's coronary sinus by adjusting a relative orientation or longitudinal position of the inner catheter relative to the outer catheter, longitudinally sliding the outer catheter over the distal end of the inner catheter to deep seat the outer catheter within the patient's coronary sinus, and delivering a payload to the destination vessel through the outer catheter or the inner catheter.07-29-2010
20110009750CARDIOVASCULAR IMAGING SYSTEM - Embodiments of the present invention include a laser catheter that includes a catheter body, a light guide, and a distal tip that extends beyond the exit aperture of the light guide. In some embodiments, an imaging device is disposed on the distal tip such that the imaging device is distal relative to the exit aperture of the light guide. In some embodiments, the imaging device can be gated to record images during and/or slightly beyond periods when the laser catheter is not activated.01-13-2011
20110208207Endocardial lead removing apparatus - The invention provides an apparatus having a tubular member for receiving an endocardial lead implanted within a patient's body. Disposed generally at a distal end of the tubular member is at least one blade or cutting surface. An adjustment mechanism moves the blade between retracted and extended positions to engage the cutting surface with the endocardial lead to cut the lead. Once severed, the cut portion of the lead remains within an inner channel of the tubular member and the apparatus and cut portion of the lead are removed from within the patient. Various embodiments include the blade pivotally connected to the distal end of the tubular member and activated by a wire adjustment mechanism. Others include a metallic wire for slicing through the lead. Still others include a pneumatically actuated adjustment mechanism that inflates to move the blade and engage the cutting surface with the lead.08-25-2011
20120095479Endocardial Lead Removing Apparatus - The invention provides an apparatus having a tubular member for receiving an endocardial lead implanted within a patient's body. Disposed generally at a distal end of the tubular member is at least one blade or cutting surface. An adjustment mechanism moves the blade between retracted and extended positions to engage the cutting surface with the endocardial lead to cut the lead. Once severed, the cut portion of the lead remains within an inner channel of the tubular member and the apparatus and cut portion of the lead are removed from within the patient. Various embodiments include the blade pivotally connected to the distal end of the tubular member and activated by a wire adjustment mechanism. Others include a metallic wire for slicing through the lead. Still others include a pneumatically actuated adjustment mechanism that inflates to move the blade and engage the cutting surface with the lead.04-19-2012
20130184598INNER AND OUTER TELESCOPING CATHETER DELIVERY SYSTEM - A catheter assembly employs an outer catheter with a pre-formed distal end and an open lumen. An inner catheter having an open lumen and a pre-formed distal end is movably disposed within the outer catheter. Relative rotation and extension of the inner and outer catheters provides the distal end of the catheter assembly with an adjustable range of two- and three-dimensional shapes. The inner catheter can include sections of varying stiffness, such that extension of the inner catheter within the outer catheter modifies the shape of the outer catheter's pre-formed distal end. One or both of the outer and inner catheters includes an occlusion balloon attached to the distal end thereof. The adjustable shaping of the catheter assembly's distal tip provides an improved system for locating and cannulating cardiac venous structures, particularly the coronary sinus via the right atrium.07-18-2013
20140081252TISSUE SLITTING METHODS AND SYSTEMS - Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.03-20-2014
20140081303TISSUE SLITTING METHODS AND SYSTEMS - Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.03-20-2014
20140081304TISSUE SLITTING METHODS AND SYSTEMS - Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.03-20-2014
20140081306TISSUE SLITTING METHODS AND SYSTEMS - Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.03-20-2014
20140371718REENTRY CATHETHER AND METHOD THEREOF - Embodiments of the invention are directed towards a rapid exchange catheter configured for insertion into a subintimal space and crossing an occlusion in a subintimal space. The catheter includes a proximal end, a distal end, a first lumen configured to receive a first wire, the first lumen extending longitudinally through a least a lateral port of the catheter, and a second lumen having at least a portion distal of the lateral port and extending through at least the distal end of the catheter. The catheter also includes an exchange port arranged on a exterior portion of the catheter configured to the receive a second wire and second rapid exchange port in communication with the second lumen. Moreover, other embodiments of the invention are directed towards methods for using the rapid exchange catheter to cross an obstruction in a vessel, e.g., a total or partial occlusion, in a subintimal space.12-18-2014

Patent applications by Wade A. Bowe, Colorado Springs, CO US

Whitney Bowe, Brooklyn, NY US

Patent application numberDescriptionPublished
20100056423Bacterial-Derived BLIS for Treatment of Acne - This invention relates to a treatment of acne. Specifically, the invention is directed to the use of bacteriocin-like inhibitory substances (BLIS), isolated from 03-04-2010

Whitney Bowe, Chappaqua, NY US

Patent application numberDescriptionPublished
20130203653BACTERIAL-DERIVED BLIS FOR TREATMENT OF ACNE - This invention relates to a treatment of acne. Specifically, the invention is directed to the use of bacteriocin-like inhibitory substances (BLIS), isolated from 08-08-2013
Website © 2015 Advameg, Inc.